LGALS1 and gastric cancer: Importantly, the administration of OTX008, a GAL-1 inhibitor, exerted a synergistic effect with a nab-paclitaxel treatment on nude mice, particularly humanized NSG mice, indicating that the inhibition of GAL-1 reversed the nab-paclitaxel resistance of GC.